VH
INSIDER · NRIX · Nurix Therapeutics, Inc. · CHIEF FINANCIAL OFFICER
van Houte Hans
Every open-market transaction filed under this name, Oct 30 to Nov 4.
Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$149K
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Nov 4 | NRIX | Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 1,469 | $16.20 | $24K | −1.6% |
| Nov 4 | NRIX | Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 3,300 | $15.38 | $51K | +3.6% |
| Oct 30 | NRIX | Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 2,834 | $26.28 | $74K | −39.3% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.